These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5443653)

  • 41. A clinical evaluation of an injectable phenothiazine in the management of acute psychotic patients.
    Verster JP
    S Afr Med J; 1967 Jan; 41(4):83-4. PubMed ID: 5335781
    [No Abstract]   [Full Text] [Related]  

  • 42. Haloperidol in the treatment of behavioural disorders in children and adolescents.
    Le Vann LJ
    Can Psychiatr Assoc J; 1969 Apr; 14(2):217-20. PubMed ID: 5783784
    [No Abstract]   [Full Text] [Related]  

  • 43. Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
    van Praag HM; Dols LC
    Am J Psychiatry; 1973 Jul; 130(7):801-4. PubMed ID: 4576449
    [No Abstract]   [Full Text] [Related]  

  • 44. Experience with fluphenazine hydrochloride injection.
    Zabow T
    S Afr Med J; 1985 Jan; 67(4):118. PubMed ID: 3969594
    [No Abstract]   [Full Text] [Related]  

  • 45. Efficacy of haloperidol in drug refractory patients.
    Ban TA; Lehmann HE
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:78-86. PubMed ID: 4383142
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluphenazine treatment in the psychotic child: clinical-evoked potential correlations.
    Saletu B; Saletu M; Simeon J; Marasa J
    Compr Psychiatry; 1975; 16(3):265-78. PubMed ID: 1139924
    [No Abstract]   [Full Text] [Related]  

  • 47. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.
    Anderson LT; Campbell M; Grega DM; Perry R; Small AM; Green WH
    Am J Psychiatry; 1984 Oct; 141(10):1195-202. PubMed ID: 6385731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Electroencephalographic effects of fluphonazine decanoate].
    Borenstein P; Cujo P; Dumaine A
    Ann Med Psychol (Paris); 1970 Jul; 2(2):273-5. PubMed ID: 5475414
    [No Abstract]   [Full Text] [Related]  

  • 49. A classification of schizophrenic children under five years.
    Fish B; Shapiro T; Campbell M; Wile R
    Am J Psychiatry; 1968 Apr; 124(10):1415-23. PubMed ID: 5643660
    [No Abstract]   [Full Text] [Related]  

  • 50. Haloperidol in psychiatry.
    Med Lett Drugs Ther; 1975 Jan; 17(3):11-2. PubMed ID: 1092991
    [No Abstract]   [Full Text] [Related]  

  • 51. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
    [No Abstract]   [Full Text] [Related]  

  • 52. Hyperkinesias in a prepubertal boy with autistic disorder treated with haloperidol and valproic acid.
    Brasić JR; Barnett JY
    Psychol Rep; 1997 Feb; 80(1):163-70. PubMed ID: 9122323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Affective disorders in the course of treatment with neuroleptics of children and adolescents with schizophrenia].
    Semanovskaia EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(10):1529-34. PubMed ID: 4386295
    [No Abstract]   [Full Text] [Related]  

  • 54. [Indications and modes of administration of fluphenazine enanthate].
    Fouks L; Périvier E; Houssait A; Gilbert ; Ferragus ; Lerno M
    Ann Med Psychol (Paris); 1967 Jul; 125(2):276-82. PubMed ID: 6076191
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of oral haloperidol following rapid tranquilization of acutely disturbed patients.
    Carter RG
    W V Med J; 1978 Mar; 74(3):55-6. PubMed ID: 272805
    [No Abstract]   [Full Text] [Related]  

  • 56. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive and linguistic deficits in psychotic children.
    Hagen JW; Winsberg BG; Wolff P
    Child Dev; 1968 Dec; 39(4):1103-17. PubMed ID: 5704390
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical experiences with a delayed-action preparation of fluphenazine].
    Schwingenheuer J
    Arzneimittelforschung; 1972 Nov; 22(11):1918-21. PubMed ID: 4633589
    [No Abstract]   [Full Text] [Related]  

  • 60. A comparison of haloperidol, behavior therapy, and their interaction in autistic children [proceedings].
    Campbell M; Anderson LT; Meier M
    Psychopharmacol Bull; 1979 Apr; 15(2):84-6. PubMed ID: 373009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.